Assisted Dying Returns to France’s Lower House After Senate Block

France’s long-running debate over assisted dying is back in motion after lawmakers in the National Assembly moved to revive legislation that had been stalled by the upper chamber only days earlier.

On Wednesday, the Social Affairs Committee of the National Assembly approved a renewed version of the assisted dying bill, reopening a process that many had assumed was temporarily frozen following its rejection by the Senate last week. The committee’s decision clears the way for a full parliamentary debate, scheduled to begin in mid-February, with a formal vote planned for 24 February.

The bill, first introduced in 2024 and backed by President Emmanuel Macron after his re-election, had already passed the lower house once, in May 2025. Its journey was interrupted on 28 January, when senators voted it down by a clear margin, forcing the proposal back to the Assembly for reconsideration under France’s legislative process.

This latest version closely resembles the text previously approved by deputies, with one notable adjustment. The committee removed an explicit clause that excluded cases based solely on psychological suffering from eligibility. Supporters argue the change restores coherence to the bill, while critics warn it risks widening access beyond what was initially intended. Whether that concern will translate into amendments on the Assembly floor remains to be seen.

If adopted again by deputies, the bill will return to the Senate for another reading. Should lawmakers in the two chambers fail to agree, the National Assembly ultimately holds the power to impose a final version — a constitutional mechanism that gives the lower house a decisive role in protracted legislative standoffs.

At its core, the proposal would establish a legal right to assisted dying for adults suffering from serious and incurable illnesses in an advanced or terminal stage. Eligibility would be limited to patients experiencing constant and unbearable pain that cannot be relieved by treatment, and whose request is judged to be voluntary and informed.

Under the framework, patients capable of self-administering lethal medication would do so independently. Medical assistance would be permitted only when physical limitations make that impossible. Each case would require validation by a medical team composed of at least two physicians and a nurse.

The bill also includes protections for healthcare workers, allowing them to opt out on grounds of conscience, provided they direct patients to alternative professionals willing to participate.

The renewed debate highlights the unresolved ethical and political tensions surrounding end-of-life care in France. While opinion polls have suggested broad public support for some form of assisted dying, opposition within Parliament remains strong and cross-cutting, spanning ideological, religious and medical lines.

With the government aiming for adoption by the summer, the coming weeks are likely to test not only parliamentary arithmetic, but also France’s ability to navigate one of the most sensitive social issues of its time — once again, and with little room for quiet compromise.